Literature DB >> 12659143

The role of apoptosis in response to photodynamic therapy: what, where, why, and how.

Nancy L Oleinick1, Rachel L Morris, Irina Belichenko.   

Abstract

Photodynamic therapy (PDT), a treatment for cancer and for certain benign conditions, utilizes a photosensitizer and light to produce reactive oxygen in cells. PDT is primarily employed to kill tumor and other abnormal cells, so it is important to ask how this occurs. Many of the photosensitizers currently in clinical or pre-clinical studies of PDT localize in or have a major influence on mitochondria, and PDT is a strong inducer of apoptosis in many situations. The purpose of this review is to critically evaluate all of the recently published research on PDT-induced apoptosis, with a focus on studies providing mechanistic insights. Components of the mechanism whereby PDT causes cells to undergo apoptosis are becoming understood, as are the influences of several signal transduction pathways on the response. Future research should be directed to elucidating the role(s) of the multiple steps in apoptosis in directing damaged cells to an apoptotic vs. necrotic pathway and for producing tumor ablation in conjunction with tissue-level mechanisms operating in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12659143     DOI: 10.1039/b108586g

Source DB:  PubMed          Journal:  Photochem Photobiol Sci        ISSN: 1474-905X            Impact factor:   3.982


  210 in total

1.  Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects.

Authors:  Eleonora Reginato; Peter Wolf; Michael R Hamblin
Journal:  World J Immunol       Date:  2014-03-27

Review 2.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Binding to and photo-oxidation of cardiolipin by the phthalocyanine photosensitizer Pc 4.

Authors:  Myriam E Rodriguez; Junhwan Kim; Grace B Delos Santos; Kashif Azizuddin; Jeffrey Berlin; Vernon E Anderson; Malcolm E Kenney; Nancy L Oleinick
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

4.  Light-Activated Pharmaceuticals: Mechanisms and Detection.

Authors:  David Kessel; John Reiners
Journal:  Isr J Chem       Date:  2012-09-01       Impact factor: 3.333

5.  Target-selective phototherapy using a ligand-based photosensitizer for type 2 cannabinoid receptor.

Authors:  Shaojuan Zhang; Ningyang Jia; Pin Shao; Qin Tong; Xiang-Qun Xie; Mingfeng Bai
Journal:  Chem Biol       Date:  2014-02-27

6.  Effect of molecular characteristics on cellular uptake, subcellular localization, and phototoxicity of Zn(II) N-alkylpyridylporphyrins.

Authors:  Rima Ezzeddine; Anwar Al-Banaw; Artak Tovmasyan; James D Craik; Ines Batinic-Haberle; Ludmil T Benov
Journal:  J Biol Chem       Date:  2013-11-08       Impact factor: 5.157

7.  Choline PET for monitoring early tumor response to photodynamic therapy.

Authors:  Baowei Fei; Hesheng Wang; Chunying Wu; Song-mao Chiu
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

8.  Low concentrations of a non-hydrolysable tetra-S-glycosylated porphyrin and low light induces apoptosis in human breast cancer cells via stress of the endoplasmic reticulum.

Authors:  Sebastian Thompson; Xin Chen; Li Hui; Alfredo Toschi; David A Foster; Charles Michael Drain
Journal:  Photochem Photobiol Sci       Date:  2008-08-18       Impact factor: 3.982

9.  Apoptosis of gastric cancer cell line MKN45 by photodynamic treatment with photofrin.

Authors:  Kenichiro Takahira; Munetaka Sano; Hajime Arai; Hiroyuki Hanai
Journal:  Lasers Med Sci       Date:  2004       Impact factor: 3.161

10.  Atg7 deficiency increases resistance of MCF-7 human breast cancer cells to photodynamic therapy.

Authors:  Liang-Yan Xue; Song-Mao Chiu; Nancy L Oleinick
Journal:  Autophagy       Date:  2010-03-02       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.